Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up studyDiabetologia, 2012-01, Vol.55 (1), p.51-62 [Peer Reviewed Journal]The Author(s) 2011 ;2015 INIST-CNRS ;Springer-Verlag 2012 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-011-2312-4 ;PMID: 21956710Full text available |
|
2 |
Material Type: Article
|
Ten Years of Experience with Biphasic Insulin Aspart 30: From Drug Development to the Latest Clinical FindingsDrugs (New York, N.Y.), 2012-01, Vol.72 (11), p.1495-1520 [Peer Reviewed Journal]Springer International Publishing AG 2012 ;2015 INIST-CNRS ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.2165/11635490-000000000-00000 ;PMID: 22818015 ;CODEN: DRUGAYFull text available |
|
3 |
Material Type: Article
|
Insulin analogues and their potential in the management of diabetes mellitusDiabetologia, 1999-10, Vol.42 (10), p.1151-1167 [Peer Reviewed Journal]1999 INIST-CNRS ;Springer-Verlag Berlin Heidelberg 1999 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s001250051286 ;PMID: 10525654Full text available |
|
4 |
Material Type: Article
|
Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trialThe Lancet (British edition), 2012-04, Vol.379 (9825), p.1489-1497 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 21-Apr 27, 2012 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60204-9 ;PMID: 22521071 ;CODEN: LANCAOFull text available |
|
5 |
Material Type: Article
|
Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal InsulinPharmaceutical research, 2012-08, Vol.29 (8), p.2104-2114 [Peer Reviewed Journal]The Author(s) 2012 ;2015 INIST-CNRS ;Springer Science+Business Media, LLC 2012 ;ISSN: 0724-8741 ;EISSN: 1573-904X ;DOI: 10.1007/s11095-012-0739-z ;PMID: 22485010 ;CODEN: PHREEBFull text available |
|
6 |
Material Type: Article
|
One-Year Treatment With Exenatide Improves β-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients: A randomized, controlled trialDiabetes care, 2009-05, Vol.32 (5), p.762-768 [Peer Reviewed Journal]2009 INIST-CNRS ;2009 by the American Diabetes Association. 2009 ;ISSN: 0149-5992 ;ISSN: 1935-5548 ;EISSN: 1935-5548 ;DOI: 10.2337/dc08-1797 ;PMID: 19196887 ;CODEN: DICAD2Full text available |
|
7 |
Material Type: Article
|
Lower Within-Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 DiabetesDiabetes (New York, N.Y.), 2004-06, Vol.53 (6), p.1614-1620 [Peer Reviewed Journal]2004 INIST-CNRS ;COPYRIGHT 2004 American Diabetes Association ;Copyright American Diabetes Association Jun 2004 ;ISSN: 0012-1797 ;EISSN: 1939-327X ;DOI: 10.2337/diabetes.53.6.1614 ;PMID: 15161770 ;CODEN: DIAEAZFull text available |
|
8 |
Material Type: Article
|
Insulin AnaloguesThe New England journal of medicine, 2005-01, Vol.352 (2), p.174-183 [Peer Reviewed Journal]Copyright © 2005 Massachusetts Medical Society. All rights reserved. ;2005 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra040832 ;PMID: 15647580 ;CODEN: NEJMAGFull text available |
|
9 |
Material Type: Article
|
Insulin is a potent myeloma cell growth factor through insulin IGF-1 hybrid receptor activationLeukemia, 2010-11, Vol.24 (11), p.1940-1950 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2010 Nature Publishing Group ;COPYRIGHT 2010 Nature Publishing Group ;Macmillan Publishers Limited 2010. ;Copyright Nature Publishing Group Nov 2010 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/leu.2010.192 ;PMID: 20844560 ;CODEN: LEUKEDFull text available |
|
10 |
Material Type: Article
|
Basal Insulin and Cardiovascular and Other Outcomes in DysglycemiaThe New England journal of medicine, 2012-07, Vol.367 (4), p.319-328 [Peer Reviewed Journal]Copyright © 2012 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1203858 ;PMID: 22686416 ;CODEN: NEJMAGFull text available |
|
11 |
Material Type: Article
|
Conversion of adult pancreatic α-cells to β-cells after extreme β-cell lossNature (London), 2010-04, Vol.464 (7292), p.1149-1154 [Peer Reviewed Journal]2015 INIST-CNRS ;COPYRIGHT 2010 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature08894 ;PMID: 20364121 ;CODEN: NATUASFull text available |
|
12 |
Material Type: Article
|
Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET studyDiabetologia, 2006-03, Vol.49 (3), p.442-451 [Peer Reviewed Journal]2006 INIST-CNRS ;Springer-Verlag 2006 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-005-0132-0 ;PMID: 16456680Full text available |
|
13 |
Material Type: Article
|
Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaThe New England journal of medicine, 2013-07, Vol.369 (3), p.224-232 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1303576 ;PMID: 23789889 ;CODEN: NEJMAGFull text available |
|
14 |
Material Type: Article
|
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes: A pilot, randomized, controlled studyDiabetes care, 2013-11, Vol.36 (11), p.3430-3435 [Peer Reviewed Journal]2014 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Nov 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0277 ;PMID: 23877988 ;CODEN: DICAD2Full text available |
|
15 |
Material Type: Article
|
Pharmacokinetic and glucodynamic variability : assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp techniqueDiabetologia, 2005-10, Vol.48 (10), p.1988-1995 [Peer Reviewed Journal]2005 INIST-CNRS ;Springer-Verlag 2005 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-005-1916-y ;PMID: 16160867Full text available |
|
16 |
Material Type: Article
|
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2Diabetologia, 2012-10, Vol.55 (10), p.2565-2582 [Peer Reviewed Journal]Springer-Verlag 2012 ;2015 INIST-CNRS ;Springer-Verlag 2012 2012 ;ISSN: 0012-186X ;EISSN: 1432-0428 ;DOI: 10.1007/s00125-012-2644-8 ;PMID: 22869320Full text available |
|
17 |
Material Type: Article
|
Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy SubjectsDiabetes care, 2014-09, Vol.37 (9), p.2609-2615 [Peer Reviewed Journal]2015 INIST-CNRS ;2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. ;Copyright American Diabetes Association Sep 2014 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc14-0210 ;PMID: 24947791 ;CODEN: DICAD2Full text available |
|
18 |
Material Type: Article
|
The treat-to-target trial: Randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patientsDiabetes care, 2003-11, Vol.26 (11), p.3080-3086 [Peer Reviewed Journal]2004 INIST-CNRS ;Copyright American Diabetes Association Nov 2003 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/diacare.26.11.3080 ;PMID: 14578243 ;CODEN: DICAD2Full text available |
|
19 |
Material Type: Article
|
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and futureThe Lancet (British edition), 2014-03, Vol.383 (9922), p.1068-1083 [Peer Reviewed Journal]Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 22, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62154-6 ;PMID: 24315620 ;CODEN: LANCAOFull text available |
|
20 |
Material Type: Article
|
Do high fasting glucose levels suggest nocturnal hypoglycaemia? The Somogyi effect-more fiction than fact?Diabetic medicine, 2013-08, Vol.30 (8), p.914-917 [Peer Reviewed Journal]2013 The Authors. Diabetic Medicine © 2013 Diabetes UK ;2014 INIST-CNRS ;2013 The Authors. Diabetic Medicine © 2013 Diabetes UK. ;ISSN: 0742-3071 ;EISSN: 1464-5491 ;DOI: 10.1111/dme.12175 ;PMID: 23672623 ;CODEN: DIMEEVFull text available |